Showing results (1631-1640 of 3,549) with videos related to
Sort By:
Pageof 355
Prevention Science : the Official Journal of the Society for Prevention Research|April 28, 2010
Testing the universality of the effects of the communities that care prevention system for preventing adolescent drug use and delinquencySabrina Oesterle, J David Hawkins, Abigail A Fagan, et al.Clinical Pharmacology and Therapeutics|January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololT Walle, E C Conradi, U K Walle, et al.The Journal of Biological Chemistry|March 27, 2001
Different regulatory mechanisms modulate the expression of a dinoflagellate iron-superoxide dismutaseO K Okamoto, D L Robertson, T F Fagan, et al.Journal of Molecular Biology|February 28, 1997
Mapping sequence specific DNA-protein interactions: a versatile, quantitative method and its application to transcription factor XF1B Luo, D J Perry, L Zhang, et al.Tropical Doctor|February 27, 2014
Initiating and developing clinical services, training and research in a low resource setting: the Malawi ENT experienceWakisa Mulwafu, Thomas Elliot Nyirenda, Johannes J Fagan, et al.Journal of Public Health Policy|January 1, 1990
Termination of health benefits for Pittston mine workers: impact on the health and security of miners and their familiesR Y Demers, C W Michaels, R Frank, et al.Clinical Pharmacology and Therapeutics|August 1, 1979
Presystemic and systemic glucuronidation of propranololT Walle, T C Fagan, E C Conradi, et al.Stroke|July 31, 2004
Targets for vascular protection after acute ischemic strokeSusan C Fagan, David C Hess, Elizabeth J Hohnadel, et al.Psychiatric Medicine|January 11, 1992
The five-factor model of personality and sexual functioning in outpatient men and womenP T Costa, P J Fagan, R L Piedmont, et al.Hepatology (Baltimore, Md.)|July 1, 1991
Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver diseaseW L Hutchinson, Y S White, E A Fagan, et al.Pageof 355